Skip to content

Comparison of skin graft healing after harvesting with and without tumescent techniques.

A Comparitive Study of Split Thickness Skin Graft Take Following Harvesting With Tumescent Technique versus Non-Tumescent Technique. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102418
Enrollment
50
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V239- Unspecified motorcycle rider injured in collision with car, pick-up truck or van in traffic accident

Interventions

Intervention1: NIL: NIL Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Patient: Harvesting of split-thickness skin graft using tumescent techniqe.

Sponsors

DR ARUL D C
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria Patients aged 18 65 years. Indicated for split-thickness skin grafting due to trauma, burns, or post- excisional defects. Hemodynamically stable. Willing to provide informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Known allergy to lignocaine or epinephrine. Coagulopathies or on anticoagulation therapy. Active infection at the donor or recipient site. Uncontrolled diabetes or peripheral vascular disease.

Design outcomes

Primary

MeasureTime frame
Percentage of graft take assessed clinically on postoperative day 5 in patients undergoing split-thickness skin graft harvesting using tumescent versus non-tumescent technique.Timepoint: Percentage of graft take assessed clinically on postoperative day 5 in patients undergoing split-thickness skin graft harvesting using tumescent versus non-tumescent technique.

Secondary

MeasureTime frame
Intraoperative blood loss measured during split-thickness skin graft harvesting in both groups. Postoperative pain at the donor site assessed using Visual Analog Scale (VAS) on postoperative days 1, 2, and 3 Percentage of donor site epithelialization assessed on postoperative day 10. Incidence of postoperative complications including hematoma, seroma, and infection at donor and recipient sites during the postoperative follow-up period of 3 week Final clinical outcome of graft and donor sites assessed at 3 weeks postoperatively. Timepoint: 18 weeks

Countries

India

Contacts

Public ContactDR ARUL D C

Vinayaka Mission s Kirupananda Variyar Medical College, Salem

emjkarthik@gmail.com9842256564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026